Maintaining sugar levels in a brain protein known as tau could slow or prevent Alzheimer's disease (Image: Shutterstock)
Simon Fraser University chemistry professor David Vocadlo
We’ve reported on numerous different approaches by scientists looking to tackle Alzheimer’s disease. While some, such as the anticancer drug bexarotene and a compound known as J147, show great promise, there is still no approved treatment to slow the disease’s progression. The latest promising candidate for a treatment comes from Canada’s Simon Fraser University (SFU), where a team has concluded that ensuring that sugar levels in a brain protein known as tau are maintained could slow or prevent the fatal disease.
Other Images from this Gallery